Toggle Offcanvas
...
 
Ipilimumab Tenders

Ipilimumab Tenders

View Ipilimumab tenders, RFPs and contracts. Bid on readily available Ipilimumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Ipilimumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Ipilimumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Ipilimumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Ipilimumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

3 Live Notices for Ipilimumab Tenders

Showing 1 to 3

Acquisition Of Chemotherapy Drugs With Cold Chain, For The Pharmacy Division.
country Argentina
posting date01 Feb 2025
deadline21 Feb 2025
Lpn No. 01/2025 "Acquisition Of Medicines For Oncological Patients At Incan And Other Centers Depending On The Ministry Of Public Health And Social Welfare - Ad Referendum To The Pgn 2025 - Multi-Year - Open Contract"
country Paraguay
posting date01 Feb 2025
deadline19 Feb 2025
Delivery Of Medicinal Products - Delivery Of Nivolumab And Ipilimumab Medicines
country Poland
posting date21 Jan 2025
deadline18 Feb 2025

Share Share this page